Viewing Study NCT06611657


Ignite Creation Date: 2025-12-24 @ 6:51 PM
Ignite Modification Date: 2026-01-18 @ 1:49 PM
Study NCT ID: NCT06611657
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-10-16
First Post: 2024-09-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Antirotinib Hydrochloride Plus Whole Brain Radiotherapy for Small Cell Lung Cancer With Brain Metastases
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-08-20
Start Date Type: ACTUAL
Primary Completion Date: 2024-06-10
Primary Completion Date Type: ACTUAL
Completion Date: 2025-07-30
Completion Date Type: ESTIMATED
First Submit Date: 2024-09-22
First Submit QC Date: None
Study First Post Date: 2024-09-25
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-10-14
Last Update Post Date: 2024-10-16
Last Update Post Date Type: ACTUAL